Hjem › Autoimmune sygdomme › Maryland
Autoimmune sygdomme kliniske forsøg i Maryland
21 studier for Autoimmune sygdomme søger deltagere på steder i Maryland.
Byer i Maryland
Officiel studietekst (engelsk)
Etiology, Pathogenesis, and Natural History of Idiopathic CD4+ Lymphocytopenia
- National Institutes of Health Clinical Center, Bethesda
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT00867269NIAID Centralized Sequencing Protocol
- National Institutes of Health Clinical Center, Bethesda
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
1 Day – 100 Years · Alle køn · Opdateret 2. okt. 2026 · NCT03206099Natural History of Bronchiectasis
- National Institutes of Health Clinical Center, Bethesda
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 5 til 100 · Alle køn · Opdateret 2. okt. 2026 · NCT00943514Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of Immunity
- National Institutes of Health Clinical Center, Bethesda
RekruttererFase 2
Alder 4 til 69 · Alle køn · Opdateret 28. sep. 2026 · NCT04339777Environmental Risk Factors for the Anti-synthetase Syndrome
- National Institutes of Health Clinical Center, Bethesda
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 2 til 100 · Alle køn · Opdateret 28. sep. 2026 · NCT01276470Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies
- National Institutes of Health Clinical Center, Bethesda
RekruttererFase 2Frivillige med god helbredstilstand velkomne
Alder 4 til 75 · Alle køn · Opdateret 28. sep. 2026 · NCT02579967Safety of Belimumab in People With Idiopathic CD4 Lymphopenia and Autoantibodies (Phoebe)
- National Institutes of Health Clinical Center, Bethesda
RekruttererFase 1
Alder 18 til 70 · Alle køn · Opdateret 28. sep. 2026 · NCT04097561Study of Autoimmune Lymphoproliferative Syndrome (ALPS)
- National Institutes of Health Clinical Center, Bethesda
RekruttererObservationsstudie
Op til 99 år · Alle køn · Opdateret 24. sep. 2026 · NCT00001350Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell Death
- National Institutes of Health Clinical Center, Bethesda
RekruttererObservationsstudie
1 Month – 100 Years · Alle køn · Opdateret 24. sep. 2026 · NCT00246857Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 23. sep. 2026 · NCT03816345Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- National Naval Medical Center, Bethesda
- National Institutes of Health Clinical Center, Bethesda
RekruttererFase 2
Alder 18 til 90 · Alle køn · Opdateret 22. sep. 2026 · NCT00977977A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- American Oncology Partners of Maryland, PA, Bethesda
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 18. sep. 2026 · NCT06722235RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
- National Institutes of Health - Accepting Adult and Juvenile Patients, Bethesda
RekruttererFase 2/3
Alder 6 til 75 · Alle køn · Opdateret 17. sep. 2026 · NCT06154252Ublituximab in Autoantibody Positive Immune Mediated Necrotizing Myopathy
- Johns Hopkins Hospital: Division of Rheumatology, Baltimore
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 17. sep. 2026 · NCT07103746Daratumumab in Primary Antiphospholipid Syndrome
- Johns Hopkins University, Baltimore
RekruttererFase 1/2
Alder 18 til 65 · Alle køn · Opdateret 16. sep. 2026 · NCT05671757A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
- Johns Hopkins Hospital, Baltimore
RekruttererFase 1
Alder 18 til 74 · Alle køn · Opdateret 10. sep. 2026 · NCT07085104PS-002 for the Treatment of IgA Nephropathy in Adults
- The Johns Hopkins Hospital, Baltimore
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 9. sep. 2026 · NCT07182227A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrome
- National Institutes of Health Clinical Center, Bethesda
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 10. jul. 2026 · NCT05027945A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- Johns Hopkins, Baltimore
- Nih/Niaid, Bethesda
- Nih/Nhlbi, Bethesda
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 6. jul. 2026 · NCT01351545Early Initiation of Oral Therapy With Cyclosporine and Eltrombopag for Treatment Naive Severe Aplastic Anemia (SAA)
- National Institutes of Health Clinical Center, Bethesda
RekruttererFase 2
Alder 3 til 99 · Alle køn · Opdateret 9. mar. 2026 · NCT04304820X-linked Moesin Associated Immunodeficiency
- National Institutes of Health, Bethesda
RekruttererObservationsstudie
Alder 4 til 80 · Mænd · Opdateret 25. apr. 2025 · NCT06278337Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.